Table 1.

Immunologic characteristics of the adult study populationg

SubjectaSerum characteristicsEpithelial neutralizationFibroblast neutralization
SerumSalivaSerum
gB-ELISAAviditybUL130cIC50dRangeeIC50dRangee,fIC50dRangee
A1102,400371,124962–1,314<2NA186122–285
A26,40047303223–393<2NA6733–136
A325,60046534441–648<2NA178105–301
A4102,400331,7771,578–2,0046.86–8453341–602
A525,600411,2331,081–1,407<2NA256105–629
A625,600493,6863,405–3,998<2NA7351–104
A725,600525,0314,401–5,760<2NA254207–313
A825,60049+3,6303,307–3,9865.75–610188–117
A9102,400353,0722,742–3,435<2NA188163–217
M125,600312,2611,863–2,74010.05–18237210–267
M2256,20051+15,09413,233–17,23221.415–30835568–1,230
M3102,400213,1392,642–3,73313.24–39253215–298
M4256,20056+16,11714,861–17,45627.925–32364323–410
M525,600381,8081,371–2,3828.83–283930–51
M6102,40045+7,1225,985–8,49121.018–24150101–222
M725,60039181151–218<2NA5225–111
  • a Subjects A1 to A9 are non-daycare-associated adults; subjects M1 to M7 are daycare-associated mothers.

  • b <35, low; 35 to 45, medium; >45, high.

  • c Determined by immunoblotting. +, antibodies detected; −, antibodies not detected.

  • d Reciprocal titers.

  • e Ranges are inverse logs of the mean log(IC50) ± standard error of the mean log(IC50).

  • f NA, not applicable.

  • g Shading indicates results for individuals with high immunity to CMV.